Cargando…

Elderly CD8(+) T cells in the focus for immunotherapeutic approaches

Detalles Bibliográficos
Autores principales:	Lis, Annette, Zöphel, Dorina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258035/ https://www.ncbi.nlm.nih.gov/pubmed/37204431 http://dx.doi.org/10.18632/aging.204747

Ejemplares similares

Heterozygous OT‐I mice reveal that antigen‐specific CD8 (+) T cells shift from apoptotic to necrotic killers in the elderly
por: Zöphel, Dorina, et al.
Publicado: (2023)

Faster cytotoxicity with age: Increased perforin and granzyme levels in cytotoxic CD8 (+) T cells boost cancer cell elimination
por: Zöphel, Dorina, et al.
Publicado: (2022)

Altered Ca(2+) Homeostasis in Immune Cells during Aging: Role of Ion Channels
por: Zöphel, Dorina, et al.
Publicado: (2020)

Advances in Immunotherapeutic Approaches to Type 1 Diabetes
por: Cudini, Annamaria, et al.
Publicado: (2023)

Combinatorial immunotherapeutic approaches to restore the function of anergic tumor-reactive cytotoxic CD8(+) T cells
por: Redmond, William L., et al.
Publicado: (2016)

Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors
por: Yamamoto, Yoko, et al.
Publicado: (2020)

Orai, STIM, and PMCA contribute to reduced calcium signal generation in CD8(+) T cells of elderly mice
por: Angenendt, Adrian, et al.
Publicado: (2020)

Peptide-Based Immunotherapeutics and Vaccines
por: Reche, Pedro A., et al.
Publicado: (2014)

Immunotherapeutic Targeting in Autoimmune Diseases
por: Janikashvili, Nona, et al.
Publicado: (2016)

CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
por: Morandi, Fabio, et al.
Publicado: (2018)

Peptide-Based Immunotherapeutics and Vaccines 2015
por: Reche, Pedro, et al.
Publicado: (2015)

Peptide-Based Immunotherapeutics and Vaccines 2017
por: Reche, Pedro, et al.
Publicado: (2018)

Human vaccines and immunotherapeutics: News September 2023
por: Ellis, Ronald, et al.
Publicado: (2023)

The Long Road of Immunotherapeutics against Multiple Sclerosis †
por: Apostolopoulos, Vasso, et al.
Publicado: (2020)

A CD8(+) T cell-associated immune gene panel for prediction of the prognosis and immunotherapeutic effect of melanoma
por: Sun, Shanwen, et al.
Publicado: (2022)

Quantifying the efficacy of checkpoint inhibitors on CD8(+) cytotoxic T cells for immunotherapeutic applications via single-cell interaction
por: Sullivan, Matthew Ryan, et al.
Publicado: (2020)

New immunotherapeutic paradigms for castration-resistant prostate cancer
por: Galluzzi, Lorenzo
Publicado: (2013)

Conversion of the CD8 lineage to CD4 T cells
por: Guzman, Maria P., et al.
Publicado: (2015)

Immunotherapeutic Approaches in Ovarian Cancer
por: Yoon, Hyunho, et al.
Publicado: (2023)

Immunotherapeutic approaches for hepatocellular carcinoma
por: Longo, Vito, et al.
Publicado: (2017)

New Immunotherapeutic Approaches for Glioblastoma
por: Vázquez Cervantes, Gustavo Ignacio, et al.
Publicado: (2021)

Immunotherapeutic Approaches for Glioblastoma Treatment
por: Yaghi, Nasser K., et al.
Publicado: (2022)

Reactivation of low avidity tumor-specific CD8(+) T cells associates with immunotherapeutic efficacy of anti-PD-1
por: Sugiyarto, Gessa, et al.
Publicado: (2023)

The Diagnostic and Immunotherapeutic Value of CD248 in Renal Cell Carcinoma
por: Zhang, Keying, et al.
Publicado: (2021)

Correction: Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1
Publicado: (2023)

Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses
por: Monticone, Giulia, et al.
Publicado: (2022)

CD81 is a novel immunotherapeutic target for B cell lymphoma
por: Vences-Catalán, Felipe, et al.
Publicado: (2019)

CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma
por: Freile, Jimena Álvarez, et al.
Publicado: (2022)

Current Immunotherapeutic Approaches in Pancreatic Cancer
por: Koido, Shigeo, et al.
Publicado: (2011)

Experiences and Expectations for Glioma Immunotherapeutic Approaches
por: Yamanaka, Ryuya, et al.
Publicado: (2014)

Immunotherapeutic approaches to ovarian cancer treatment
por: Chester, Cariad, et al.
Publicado: (2015)

Phytochemicals Approach for Developing Cancer Immunotherapeutics
por: Yin, Shu-Yi, et al.
Publicado: (2017)

Immunotherapeutic approaches to curtail COVID-19
por: Owji, Hajar, et al.
Publicado: (2020)

Immunotherapeutic and Targeted Approaches in Multiple Myeloma
por: Nadeem, Omar, et al.
Publicado: (2020)

Immunotherapeutic Approaches in Malignant Pleural Mesothelioma
por: Terenziani, Rita, et al.
Publicado: (2021)

Current Immunotherapeutic Approaches for Malignant Gliomas
por: Han, Myung-Hoon, et al.
Publicado: (2022)

Editorial: Advances in Immunotherapeutic Approaches to Tuberculosis
por: Estrada García, Iris, et al.
Publicado: (2021)

Immunotherapeutic Approaches for Treating Hepatocellular Carcinoma
por: Shen, Wanying, et al.
Publicado: (2022)

Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas
por: Poggio, Teresa, et al.
Publicado: (2018)

Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic Strategies
por: Genoud, Vassilis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_42n72r3b4cnl26qqbirc6oenct